Lobbying

Evoendo's latest lobbying report covers Q4 2024, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.

Evoendo

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Evoendo lobbying by quarter
Evoendo lobbying by quarter
QuarterAmountReports
Q4 2022$10K1
Q1 2023$01
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Medicare and Medicaid$10K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)1 reports
  • HOUSE OF REPRESENTATIVES1 reports
  • SENATE1 reports

Firms it paid

Firm
Arnold & Porter Kaye Scholer$10K9 quarters

Former officials lobbying for it

Former position
BOBBY MCMILLINGeneral Counsel, Senate Committee on Health, Education, Labor, & Pensions (HELP) (2015-2019); Counsel, Senate HELP Committee (2015); Counsel, Sen. Chambliss (2013-2015); Regional Rep., Sen. Chambliss (2012-2013); Press Intern, Sen. Chambliss (2007)Q4 2022

Lobbying reports

Filed by
25/01/16for Q4 2024Arnold & Porter Kaye ScholerUnder $5,000
24/10/18for Q3 2024Arnold & Porter Kaye ScholerUnder $5,000
24/07/18for Q2 2024Arnold & Porter Kaye ScholerUnder $5,000
24/04/22for Q1 2024Arnold & Porter Kaye ScholerUnder $5,000
24/01/18for Q4 2023Arnold & Porter Kaye ScholerUnder $5,000
23/10/13for Q3 2023Arnold & Porter Kaye ScholerUnder $5,000
23/07/18for Q2 2023Arnold & Porter Kaye ScholerUnder $5,000
23/04/14for Q1 2023Arnold & Porter Kaye ScholerUnder $5,000
23/01/18for Q4 2022Arnold & Porter Kaye Scholer$10K